Literature DB >> 21742411

Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.

Jonathan Shapiro1, Arnon David Cohen, Dahlia Weitzman, Roy Tal, Michael David.   

Abstract

BACKGROUND: Previous reports demonstrated an association between psoriasis and cardiovascular disease (CVD) risk factors. However, most of these studies were based on computerized databases of outpatient clinics, which, because of International Classification of Diseases, Ninth Revision coding issues, require validation of the diagnosis of psoriasis.
OBJECTIVE: We sought to study associations between psoriasis and CVD risk factors among psoriatic inpatients compared to inpatients with dermatitis.
METHODS: A case-control study was performed using computerized medical databases from the Department of Dermatology at Rabin Medical Center in Israel. Inpatients given the diagnosis of psoriasis were compared with inpatients given the diagnosis of forms of dermatitis for the prevalence of smoking, obesity, diabetes, hypertension, hyperlipidemia, and CVD. Logistic regression models were used for multivariate analyses.
RESULTS: The study included 1079 inpatients with psoriasis and 1079 age- and gender-matched inpatients with dermatitis (control patients). A multivariate logistic regression model demonstrated that psoriasis is an independent risk factor for diabetes (odds ratio [OR] 1.43; 95% confidence interval [CI] 1.17-1.75), hypertension (OR 1.31; 95% CI 1.09-1.58), obesity (OR 1.32; 95% CI 0.99-1.76), and smoking (OR 1.38; 95% CI 1.10-1.73). Development of CVD was not significantly associated with psoriasis when correcting for diabetes, obesity, and hypertension. LIMITATIONS: Our study group was composed of inpatients only, which may be biased toward more elderly patients with severe psoriasis who may have consumed systemic treatment including immunosuppressants.
CONCLUSIONS: Our study supports previous reports of an association between psoriasis and CVD risk factors, suggesting that the inflammatory process in psoriasis, but not in dermatitis, may have a systemic impact resulting in development of CVD risk factors.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742411     DOI: 10.1016/j.jaad.2010.11.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Immune reactivity in psoriatic munro-saboureau microabscesses, stratum corneum and blood vessels.

Authors:  Ana Maria Abreu-Velez; Paul B Googe; Michael S Howard
Journal:  N Am J Med Sci       Date:  2012-06

2.  Metabolic syndrome in patients with psoriasis: A comparative study.

Authors:  Sristi Lakshmi; Amiya Kumar Nath; Carounanidy Udayashankar
Journal:  Indian Dermatol Online J       Date:  2014-04

3.  Metabolic syndrome and its components in patients with psoriasis.

Authors:  Mercè Albareda; Anna Ravella; Marta Castelló; Sandra Saborit; Laura Peramiquel; Lluís Vila
Journal:  Springerplus       Date:  2014-10-17

4.  The epidemiology of psoriatic arthritis in Israel - a population-based study.

Authors:  Lihi Eder; Arnon Dov Cohen; Ilan Feldhamer; Sari Greenberg-Dotan; Erez Batat; Devy Zisman
Journal:  Arthritis Res Ther       Date:  2018-01-02       Impact factor: 5.156

5.  Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.

Authors:  Masatoshi Abe; Chikako Nishigori; Hideshi Torii; Hironobu Ihn; Kei Ito; Makoto Nagaoka; Naoki Isogawa; Isao Kawaguchi; Yukiko Tomochika; Mihoko Kobayashi; Anna M Tallman; Kim A Papp
Journal:  J Dermatol       Date:  2017-07-17       Impact factor: 4.005

6.  The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome.

Authors:  Huynh Thi Xuan Tam; Luong Nguyen Dac Thuy; Ngo Minh Vinh; Tran Ngoc Anh; Bui Thi Van
Journal:  Dermatol Res Pract       Date:  2022-04-22

7.  The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies.

Authors:  A W Armstrong; C T Harskamp; E J Armstrong
Journal:  Nutr Diabetes       Date:  2012-12-03       Impact factor: 5.097

8.  Primary care-based screening for cardiovascular risk factors in patients with psoriasis.

Authors:  M K Rutter; K Kane; M Lunt; L Cordingley; A Littlewood; H S Young; C A Chew-Graham; R Hilton; D P M Symmons; C E M Griffiths
Journal:  Br J Dermatol       Date:  2016-07-12       Impact factor: 9.302

9.  Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis.

Authors:  Hang Zhou; Ruifang Wu; Yi Kong; Ming Zhao; Yuwen Su
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.